News

July 30, 2010:
Medicyte gains significant support from BMWi - the German Federal Ministry of Economics and Technology.
read more
June 21, 2010:
Medicyte to attend at BIO-Europe 2010 in Munich and other industry and investors meetings.
read more
March 30, 2010:
Medicyte Benefits From Multi-Million Euro EU Grant VascuBone.
read more
February 24, 2010:
Medicyte GmbH Closes Series 'A' Financing Round
read more

Startseitenbild

We are a life science company specialised in the controlled, scalable generation and standardisation of human primary cell products. Our vision is to establish our unique and proprietary technologies as gold standards and preferred source for human primary cells and human cell-based products for research, industrial and therapeutic applications. Medicyte was founded in June 2007.

MEETING WITH MEDICYTE

BIO-Europe 2010
Munich, Germany, on November 15-17, 2010
(www.ebdgroup.com)

Hepatocyte User Group and Medicon Valley Hepatocyte User Forum
Montpellier, France, on October 22-23, 2010
(www.alphavisa.com/hug-huf2010)

Biotechnica 2010
Hannover, Germany, on October 5-7, 2010
(www.biotechnica.de)

10th Annual Biotech in Europe Investor Forum
Zurich, Switzerland, on September 29-30, 2010
(www.sachsforum.com)

16th Congress on Alternatives to Animal Testing
Linz, Austria, on September 2-4, 2010
(www.eusaat.org)

New Developments in Cell-Based In-Vitro Testing
Montpellier, France, on May 26-27, 2010
(www.ivtip.org)

BIO-Equity Europe in Zurich,
Switzerland, on May 19-20, 2010
(www.biocentury.com)

IVTIP Spring Meeting in Geneva,
Switzerland, on May 18, 2010
(www.ivtip.org)



 
©
2010
ZIT!Date wurde erstellt von Ziegert IT.
by medicyte-Im Neuenheimer Feld 581-69120 Heidelberg-Germany